Removal of selected pharmaceuticals and personal care products (PPCPs) and endocrine-disrupting chemicals (EDCs) during sand filtration and ozonation at a municipal sewage treatment plant

Water Research

Volumn 41, Issue 19, 2007, Pages 4373-4382

  Nakada, Norihide ^a   Shinohara, Hiroyuki ^a   Murata, Ayako ^a   Kiri, Kentaro ^a   Managaki, Satoshi ^a   Sato, Nobuyuki ^b   Takada, Hideshige ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^b IDEA CONSULTANTS INC   (Japan)

Author keywords

Advanced treatment; Antibiotics; Endocrine disrupters; Ozonation; Pharmaceutical chemicals; Sewage treatment

Indexed keywords

ANTIBIOTICS; CONSUMER PRODUCTS; FILTRATION; OZONIZATION; PHENOLS;

ADVANCED TREATMENT; ENDOCRINE DISRUPTERS; PHARMACEUTICAL CHEMICALS;

SEWAGE TREATMENT;

4,4' ISOPROPYLIDENEDIPHENOL; ACID ANHYDRIDE; AZITHROMYCIN; CARBAMAZEPINE; CLARITHROMYCIN; CROTAMITON; DIETHYLTOLUAMIDE; ERYTHROMYCIN; ESTRADIOL; ESTRIOL; ESTRONE; FENOPROFEN; IBUPROFEN; KETOPROFEN; MEFENAMIC ACID; NAPROXEN; NONYLPHENOL; OCTYLPHENOL; PHENOL DERIVATIVE; PROPYPHENAZONE; ROXITHROMYCIN; SULFAMETHOXAZOLE; SULFAPYRIDINE; THYMOL; TRICLOSAN; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ANTIBIOTICS; CONSUMER PRODUCTS; FILTRATION; OZONIZATION; PHENOLS; SEWAGE TREATMENT;

ACTIVATED SLUDGE; ENDOCRINE DISRUPTOR; FILTRATION; OZONE; PHENOLIC COMPOUND; REMOVAL EXPERIMENT; WASTE TREATMENT; WASTEWATER;

ARTICLE; CHEMICAL STRUCTURE; FILTRATION; HYDROPHOBICITY; OZONATION; PRIORITY JOURNAL; SAND; SEWAGE TREATMENT;

EID: 35348981885     PISSN: 00431354     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.watres.2007.06.038     Document Type: Article

References (30)

1. Ahel M., and Giger W. Partitioning of alkylphenols and alkylphenol polyethoxylates between water and organic solvents. Chemosphere 26 8 (1993) 1471-1478
2. Boyd G.R., Reemtsma H., Grimm D.A., and Mitra S. Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada. Sci. Total Environ. 311 1 (2003) 135-149
3. Clara M., Strenn B., Ausserleitner M., and Kreuzinger N. Comparison of the behaviour of selected micropollutants in a membrane bioreactor and a conventional wastewater treatment plant. Water Sci. Technol. 50 5 (2004) 29-36
4. Clara M., Kreuzinger N., Strenn B., Gans O., and Kroiss H. The solids retention time-a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants. Water Res. 39 1 (2005) 97-106
5. Deborde M., Rabouan S., Duguet J.-P., and Legube B. Kinetics of aqueous ozone-induced oxidation of some endocrine disruptors. Environ. Sci. Technol. 39 16 (2005) 6086-6092
6. Dodd M., Bufle M.-O., and von Gunten U. Oxidation of antibacterial molecules by aqueous ozone: moiety-specific reaction kinetics and application to ozone-based wastewater treatment. Environ. Sci. Technol. 40 6 (2006) 1969-1977
7. Göbel A., Thomsen A., McArdell Christa S., Joss A., and Giger W. Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environ. Sci. Technol. 39 11 (2005) 3981-3989
8. Hoigné J., and Bader H. Rate constants of reactions of ozone with organic and inorganic compounds in water-I. Water Res. 17 2 (1983) 173-183
9. Hoigné J., and Bader H. Rate constants of reactions of ozone with organic and inorganic compounds in water-II. Water Res. 17 2 (1983) 185-194
10. Hua W., Bennett E.R., and Ltcher R.J. Ozone treatment and the depletion of detectable pharmaceuticals and atrazine herbicide in drinking water sourced from the upper Detroit River, Ontario, Canada. Water Res. 40 12 (2006) 2259-2266
11. Huber M.M., Canonica S., Park G.-Y., and von Gunten U. Oxidation of pharmaceuticals during ozonation and advanced oxidation processes. Environ. Sci. Technol. 37 5 (2003) 1016-1024
12. Huber M.M., Göbel A., Joss A., Hermann N., Loffler D., McArdell Christa S., Ried A., Siegrist H., Ternes Thomas A., and von Gunten U. Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: a pilot study. Environ. Sci. Technol. 39 11 (2005) 4290-4299
13. Joss A., Carballa M., Kreuzinger N., Siegrist H., and Zabczynski S. Wastewater treatment. In: Ternes T.A., and Joss A. (Eds). Human Pharmaceuticals, Hormones and Fragrances: The Challenge of Micropollutants in Urban Water Management (2006), IWA Publishing, London 243-292
14. Kidd K.A., Blanchfield P.J., Mills K.H., Palace V.P., Evans R.E., Lazorchak J.M., and Flick R.W. Collapse of a fish population after exposure to a synthetic estrogen. PNAS 104 21 (2007) 8897-8901
15. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., and Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in US Streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 36 6 (2002) 1202-1211
16. Länge R., Hutchinson T.H., Croudace C.P., Siegmund F., Schweinfurth H., Hampe P., Panter G.H., and Sumpter J.P. Effects of the synthetic estrogen 17α-ethinylestradiol on the life-cycle of the fathead minnow (Pimephales promelas). Environ. Toxicol. Chem. 20 6 (2001) 1216-1227
17. Lindqvist N., Tuhkanen T., and Kronberg L. Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. Water Res. 39 11 (2005) 2219-2228
18. McDowell D.C., Huber M.M., Wagner M., von Gunten U., and Ternes T.A. Ozonation of carbamazepine in drinking water: identification and kinetic study of major oxidation products. Environ. Sci. Technol. 39 20 (2005) 8014-8022
19. Miao X.-S., Bishay F., Chen M., and Metcalfe C.D. Occurrence of antimicrobials in the final effluents of wastewater treatment plants in Canada. Environ. Sci. Technol. 38 13 (2004) 3533-3541
20. Nakada N., Nyunoya H., Nakamura M., Hara A., Iguchi T., and Takada H. Identification of estrogenic compounds in wastewater effluent. Environ. Toxicol. Chem. 23 12 (2004) 2807-2815
21. Nakada N., Tanishima T., Shinohara H., Kiri K., and Takada H. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Res. 40 17 (2006) 3297-3303
22. Nakada N., Yasojima M., Okayasu Y., Komori K., Tanaka H., and Suzuki Y. Fate of oestrogenic compounds and identification of oestrogenicity in a wastewater treatment process. Water Sci. Technol. 53 11 (2006) 51-63
23. Paxeus N. Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, β-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment. Water Sci. Technol. 50 5 (2004) 253-260
24. Petrovic M., Diaz A., Ventura F., and Barceló D. Occurrence and removal of estrogenic short-chain ethoxy nonylphenolic compounds and their halogenated derivatives during drinking water production. Environ. Sci. Technol. 37 19 (2003) 4442-4448
25. Tajima, A., Hirayama, T., Nakajima, H., Minamiyama, M., 2005. Efficient removal of trace environmental contaminants in treated wastewater by pzonation. In: Proceedings of IWA International Conference -Chemical Industries, 2005 (CD-ROM).
26. Tauxe-Wuersch A., De Alencastro L.F., Grandjean D., and Tarradellas J. Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. Water Res. 39 9 (2005) 1761-1772
27. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 32 11 (1998) 3245-3260
28. Ternes T.A., Meisenheimer M., McDowell D., Sacher F., Brauch H.J., Haist-Gulde B., Preuss G., Wilme U., and Zulei-Seibert N. Removal of pharmaceuticals during drinking water treatment. Environ. Sci. Technol. 36 17 (2002) 3855-3863
29. von Gunten U. Ozonation of drinking water: part I. Oxidation kinetics and product formation. Water Res. 37 7 (2003) 1443-1467
30. Westerhoff P., Yoon Y., Snyder S., and Wert E. Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environ. Sci. Technol. 39 17 (2005) 6649-6663